Test Price
2,800 AED✅ Home Collection Available
ALAS2 Gene Anemia, Sideroblastic, X-Linked Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines
تحليل جين ALAS2 لفقر الدم الحديدي الأروماتي المرتبط بالصبغي X – تسلسل الجيل التالي في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
ملخص تنفيذي: فحص جيني متقدم بدقة 99.9% لتشخيص فقر الدم الحديدي الأروماتي المرتبط بطفرة جين ALAS2، مطابق لمعايير هيئة الصحة بدبي وISO 9001:2015. نقدم خدمة السحب المنزلي المبردة، استشارة وراثية إلزامية، وتوجيه طبي متابعة للنتيجة.
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Certified NGS Processing.
- Premium Logistics: Paid Hospital‑Grade Home Collection with ISO‑Certified Cold‑Chain Transport and VIP Mobile Phlebotomy (8 AM – 11 PM).
- Clinical Guidance: Telephonic Post‑Test Clinical Guidance in Result Interpretation by DHA‑Licensed Specialists.
- Insurance: Direct Billing Verification via WhatsApp at +971 54 548 8731.
Overview
The ALAS2 NGS test sequences the entire coding region of the ALAS2 gene to identify pathogenic variants responsible for X‑linked sideroblastic anemia, a rare inherited disorder of heme synthesis. يُعد هذا الفحص الجيني الدقيق أداة تشخيصية نهائية لتوجيه خطة العلاج وتقدير المخاطر العائلية.
| Aspect | Our NGS Test (ALAS2 Full Gene) | Closest Alternative (Single‑Exon Sanger / Biochemical) |
|---|---|---|
| Precision | >99.9% analytical sensitivity for all coding variants (SNVs, indels, CNVs) | 95–98% for targeted exons; misses deep intronic and copy‑number changes |
| Methodology | Next Generation Sequencing (NGS) with confirmatory Sanger for pathogenic calls | Sanger sequencing of selected exons or enzyme/protoporphyrin assays |
| Turnaround Time | 3–4 weeks with comprehensive clinical report | 2–6 weeks (often longer for full gene by fragmented testing) |
| Clinical Utility | Definitive molecular diagnosis, family screening, and genetic counseling | Partial information; may require sequential testing |
Physician Insight & Safety Protocol
“As a hematopathologist, I understand the uncertainty a suspected hereditary anemia brings to families. This NGS test provides definitive molecular proof, but must be correlated with iron studies and bone marrow evaluation to guide therapy. Our multidisciplinary team supports you from pre‑test counseling through result explanation.”
— Dr. PRABHAKAR REDDY, DHA License #61713011
⚠️ Do not discontinue prescribed medication without consulting your doctor.
Patient Safety & Exclusion Criteria
- Active infection or acute inflammatory state that may alter blood indices prior to collection.
- Known bleeding disorder or severe thrombocytopenia (platelets < 30 × 10⁹/L) – special precautions required.
- Inability to provide informed consent or absence of a legal guardian for minors (mandated by UAE CDS Law 2026).
- Recent blood transfusion within 4 weeks; if unavoidable, note in requisition.
Emergency Red Flags – Seek Immediate Medical Attention:
- Sudden chest pain, palpitations, or severe shortness of breath.
- Pallor with fainting or altered consciousness.
- High‑grade fever or signs of severe hemolysis (dark urine, jaundice).
Patient FAQ & Clinical Guidance
1. What conditions does the ALAS2 gene test diagnose?
This test diagnoses X‑linked sideroblastic anemia by detecting ALAS2 gene mutations, confirming hereditary microcytic hypochromic anemia with ringed sideroblasts. يكشف هذا الفحص بدقة عن طفرات جين ALAS2 المسببة لفقر الدم الحديدي الأروماتي المرتبط بالصبغي X، مما يؤكد التشخيص الوراثي.
2. How is the sample collected and when will I receive results?
A simple blood sample is collected at home by a certified phlebotomist, with results delivered in 3–4 weeks via secure email. يتم سحب عينة دم بسيطة في المنزل بواسطة أخصائي معتمد، وتصدر النتائج خلال 3–4 أسابيع عبر البريد الإلكتروني الآمن.
3. Is genetic counseling required before testing?
Yes, pre‑ genetic counseling is mandatory in the UAE to draw a pedigree chart and discuss implications, in compliance with DHA regulations. نعم، الاستشارة الوراثية قبل الفحص إلزامية في الإمارات لرسم شجرة العائلة ومناقشة الآثار المترتبة، وفقًا لأنظمة هيئة الصحة بدبي.
UAE Regulatory Compliance: This service adheres to Federal Decree‑Law No. 41 of 2024 on Medical Liability (Art. 87), UAE CDS Law 2026 (minors require guardian consent), and UAE PDPL for genetic data privacy. Facility License: 9834453. ISO 9001:2015 (Cert: INT/EGQ/2509DA/3139).
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians